NCT00235833View on ClinicalTrials.gov

Adalimumab in Adult Japanese Subjects With Rheumatoid Arthritis

PHASE2CompletedINTERVENTIONAL

Enrollment

25

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

October 31, 2004

Conditions

Rheumatoid Arthritis

Interventions

BIOLOGICAL

adalimumab

40 mg every other week (eow), subcutaneous (sc)

Trial Locations (7)

Unknown

Tokyo

Fukuoka

Hiroshima

Ibaraki

Nagasaki

Osaka

Saitama

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

Abbott Japan Co.,Ltd

INDUSTRY

collaborator

Eisai Co., Ltd.

INDUSTRY

lead

Abbott

INDUSTRY